Cell-based selection provides novel molecular probes for cancer stem cells

International Journal of Cancer

Volumn 132, Issue 11, 2013, Pages 2578-2588

  Sefah, Kwame ^a,b   Bae, Kyung Mi ^c   Phillips, Joseph A ^a,b   Siemann, Dietmar W ^c   Su, Zhen ^b   McClellan, Steve ^c   Vieweg, Johannes ^c   Tan, Weihong ^a,b,c,d  

^a University of Florida ^*  (United States)

^b UNIVERSITY OF FLORIDA   (United States)

^c UNIVERSITY OF FLORIDA   (United States)

^d H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

aptamers; cancer stem cell; cell SELEX; prostate cancer

Indexed keywords

ALDEHYDE DEHYDROGENASE; ALDEHYDE DEHYDROGENASE ISOENZYME 1; APTAMER; HERMES ANTIGEN; TUMOR MARKER; UNCLASSIFIED DRUG; UVOMORULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; CANCER CELL CULTURE; CANCER GROWTH; CANCER MORPHOLOGY; CANCER STEM CELL; CELL SURFACE; COMBINATORIAL CHEMISTRY; CONTROLLED STUDY; DNA SEQUENCE; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; IMMUNOPHENOTYPING; MALE; MOLECULAR PROBE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; SURFACE PROPERTY; TUMOR SPHEROID;

ANIMALS; APTAMERS, NUCLEOTIDE; FLOW CYTOMETRY; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOPHENOTYPING; MALE; MICE; MOLECULAR PROBES; NEOPLASTIC STEM CELLS; PROSTATIC NEOPLASMS; SELEX APTAMER TECHNIQUE; SPHEROIDS, CELLULAR; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 84875611438     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.27936     Document Type: Article

References (50)

1. Geiger TR, Peeper DS,. Metastasis mechanisms. Biochim Et Biophys Acta Rev Cancer 2009; 1796: 293-308.
2. Reya T, Morrison SJ, Clarke MF, et al. Stem cells, cancer, and cancer stem cells. Nature 2001; 414: 105-11.
3. Clarke MF, Dick JE, Dirks PB, et al. Cancer stem cells-perspectives on current status and future directions: AACR workshop on cancer stem cells. Cancer Res 2006; 66: 9339-44.
4. Wicha MS, Liu S, Dontu G,. Cancer stem cells: an old idea-a paradigm shift 10.1158/0008-5472.CAN-05-3153. Cancer Res 2006; 66: 1883-90.
5. Widschwendter M, Fiegl H, Egle D, et al. Epigenetic stem cell signature in cancer. Nat Genet 2007; 39: 157-8.
6. Rosen JM, Jordan CT,. The increasing complexity of the cancer stem cell paradigm. Science 2009; 324: 1670-3.
7. Hirschmann-Jax C, Foster AE, Wulf GG, et al. A distinct "side population" of cells in human tumor cells-implications for tumor biology and therapy. Cell Cycle 2005; 4: 203-5.
8. Bao S, Wu Q, McLendon RE, et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 2006; 444: 756-60.
9. Phillips TM, McBride WH, Pajonk F,. The response of CD24(-/low)/CD44(+) breast cancer-initiating cells to radiation. J Natl Cancer Inst 2006; 98: 1777-85.
10. Li XX, Lewis MT, Huang J, et al. Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy. J Natl Cancer Inst 2008; 100: 672-9.
11. Bonnet D, Dick JE,. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 1997; 3: 730-7.
12. Singh SK, Hawkins C, Clarke ID, et al. Identification of human brain tumour initiating cells. Nature 2004; 432: 396-401.
13. Al-Hajj M, Wicha MS, Benito-Hernandez A, et al. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A 2003; 100: 3983-8.
14. Shipitsin M, Campbell LL, Argani P, et al. Molecular definition of breast tumor heterogeneity. Cancer Cell 2007; 11: 259-73.
15. O'Brien CA, Pollett A, Gallinger S, et al. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 2007; 445: 106-10.
16. Ricci-Vitiani L, Lombardi DG, Pilozzi E, et al. Identification and expansion of human colon-cancer-initiating cells. Nature 2007; 445: 111-5.
17. Woodward WA, Sulman EP,. Cancer stem cells: markers or biomarkers? Cancer Metastasis Rev 2008; 27: 459-70.
18. Tuerk C, Gold L,. Systematic evolution of ligands by exponential enrichment-RNA ligands to bacteriophage-T4 DNA-polymerase. Science 1990; 249: 505-10.
19. Ellington AD, Szostak JW,. Invitro selection of RNA molecules that bind specific ligands. Nature 1990; 346: 818-22.
20. Shangguan D, Li Y, Tang ZW, et al. Aptamers evolved from live cells as effective molecular probes for cancer study. Proc Natl Acad Sci U S A 2006; 103: 11838-43.
21. Sefah K, Shangguan D, Xiong XL, et al. Development of DNA aptamers using Cell-SELEX. Nat Protocols 2010; 5: 1169-85.
22. Shangguan DH, Meng L, Cao ZHC, et al. Identification of liver cancer-specific aptamers using whole live cells. Anal Chem 2008; 80: 721-8.
23. Tang ZW, Shangguan D, Wang KM, et al. Selection of aptamers for molecular recognition and characterization of cancer cells. Anal Chem 2007; 79: 4900-7.
24. Chen HW, Medley CD, Sefah K, et al. Molecular recognition of small-cell lung cancer cells using aptamers. ChemMedChem 2008; 3: 991-1001.
25. Sefah K, Tang ZW, Shangguan DH, et al. Molecular recognition of acute myeloid leukemia using aptamers. Leukemia 2009; 23: 235-44.
26. Sefah K, Meng L, Lopez-Colon D, et al. DNA aptamers as molecular probes for Colorectal Cancer Study. Plos One 2010; 5.
27. Van Simaeys D, Lopez-Colon D, Sefah K, et al. Study of the molecular recognition of aptamers selected through ovarian cancer cell-SELEX. Plos One; 5.
28. Tang ZW, Parekh P, Turner P, et al. Generating aptamers for recognition of virus-infected cells. Clin Chem 2009; 55: 813-22.
29. Shangguan DH, Cao ZHC, Li Y, et al. Aptamers evolved from cultured cancer cells reveal molecular differences of cancer cells in patient samples. Clin Chem 2007; 53: 1153-5.
30. Shi H, Tang ZW, Kim Y, et al. In vivo fluorescence imaging of tumors using molecular aptamers generated by Cell-SELEX. Chem Asian J 5: 2209-13.
31. Mallikaratchy P, Tang ZW, Kwame S, et al. Aptamer directly evolved from live cells recognizes membrane bound immunoglobin heavy mu chain in Burkitt's lymphoma cells. Mol Cell Proteomics 2007; 6: 2230-8.
32. Shangguan D, Cao ZH, Meng L, et al. Cell-specific aptamer probes for membrane protein elucidation in cancer cells. J Proteome Res 2008; 7: 2133-9.
33. Jemal A, Siegel R, Xu JQ, et al. Cancer Statistics, 2010. CACancer J Clin 2010; 60: 277-300.
34. Coleman RE,. Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res 2006; 12: 6243S-9S.
35. Rassweiler J, Schulze M, Teber D, et al. Laparoscopic radical prostatectomy with the Heilbronn technique: oncological results in the first 500 patients. J Urol 2005; 173: 761-4.
36. Schroeder FH, Hugosson J, Roobol MJ, et al. Screening and prostate-cancer mortality in a randomized European study. N Engl J Med 2009; 360: 1320-8.
37. Andriole GL, Grubb RL, Buys SS, et al. Mortality results from a randomized prostate-cancer screening trial. N Engl J Med 2009; 360: 1310-9.
38. Wang ZA, Shen MM,. Revisiting the concept of cancer stem cells in prostate cancer. Oncogene 2011; 30: 1261-1271.
39. Dubrovska A, Kim S, Salamone RJ, et al. The role of PTEN/Akt/PI3K signaling in the maintenance and viability of prostate cancer stem-like cell populations. Proc Natl Acad Sci U S A 2009; 106: 268-73.
40. Patrawala L, Calhoun-Davis T, Schneider-Broussard R, et al. Hierarchical organization of prostate cancer cells in xenograft tumors: the CD44+α2β1+ cell population is enriched in tumor-initiating cells. Cancer Res 2007; 67: 6796-805.
41. Wei C, Wang GM, Liu YJ, et al. Cancer stem-like cells in human prostate carcinoma cells DU145-the seeds of the cell line? Cancer Biol Therapy 2007; 6: 763-8.
42. Li H, Chen X, Calhoun-Davis T, et al. PC3 human prostate carcinoma cell holoclones contain self-renewing tumor-initiating cells. Cancer Res 2008; 68: 1820-5.
43. Patrawala L, Calhoun T, Schneider-Broussard R, et al. Highly purified CD44(+) prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells. Oncogene 2006; 25: 1696-708.
44. Bae KM, Su Z, Frye C, et al. Expression of pluripotent stem cell reprogramming factors by prostate tumor initiating cells. J Urol 2010; 183: 2045-53.
45. Shi XD, Gipp J, Bushman W,. Anchorage-independent culture maintains prostate stem cells. Dev Biol 2007; 312: 396-406.
46. Ginestier C, Hur MH, Charafe-Jauffret E, et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 2007; 1: 555-67.
47. Huang EH, Hynes MJ, Zhang T, et al. Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis. Cancer Res 2009; 69: 3382-9.
48. Chen YC, Chen YW, Hsu HS, et al. Aldehyde dehydrogenase 1 is a putative marker for cancer stem cells in head and neck squamous cancer. Biochem Biophys Res Commun 2009; 385: 307-13.
49. Jiang F, Qiu Q, Khanna A, et al. Aldehyde dehydrogenase 1 is a tumor stem cell-associated marker in lung cancer. Mol Cancer Res 2009; 7: 330-8.
50. Burger PE, Gupta R, Xiong X, et al. High aldehyde dehydrogenase activity: a novel functional marker of murine prostate stem/progenitor cells. Stem Cells 2009; 27: 2220-8.